Product Information

DILTIAZEM 24H ER(CD) 300 MG CP is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.3005 per EA under NDC 50742025190. Its NADAC has been published 303 times since Nov 4, 2020.

FDA first approved this application on Jun 14, 2019. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DILTIAZEM 24H ER(CD) 300 MG CP

diltiazem hydrochloride
$0.3005per EA

Strength

300 mg/1

NDC

50742025190

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DILTIAZEM HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA208783

FDA Approved

6/14/2019

TE Code

AB3

On Market Since

6/14/2019

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A4 Inhibitors

Price Statistics

The NADAC for DILTIAZEM 24H ER(CD) 300 MG CP has been published 303 times since Nov 4, 2020, and over the history we have for it it has declined 39.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3005 per EA
All-time high$0.5441 (Jan 13, 2021)
All-time low$0.2613 (Apr 19, 2023)
52-week high$0.3098
52-week low$0.2943
Median price$0.3091
Average price$0.3424
Largest weekly change+35.3% (Aug 21, 2024)
Weeks tracked303
Tracking sinceNov 4, 2020

Price History

1W

+2.1%

1M

+0.7%

3M

-0.7%

6M

-2.8%

1Y

-1.1%

3Y

+2.5%

5Y

-24.3%

All

-39.0%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DILTIAZEM 24H ER(CD) 300 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 24H ER(CD) 300 MG CP, manufactured by Ingenus Pharmaceuticals LLC, is $0.3005 per EA (NDC 50742025190), effective Aug 19, 2026.

How has the price of DILTIAZEM 24H ER(CD) 300 MG CP changed over time?

Over the history we have for it, the NADAC for DILTIAZEM 24H ER(CD) 300 MG CP has declined 39.0%. It has been tracked across 303 weekly CMS publications since Nov 4, 2020.

What are the highest and lowest recorded NADAC prices for DILTIAZEM 24H ER(CD) 300 MG CP?

Since Nov 4, 2020, the NADAC for DILTIAZEM 24H ER(CD) 300 MG CP has ranged from a low of $0.2613 (Apr 19, 2023) to a high of $0.5441 (Jan 13, 2021), with a median of $0.3091 per EA.

Are there cheaper alternatives to DILTIAZEM 24H ER(CD) 300 MG CP?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TIADYLT ER 300 MG CAPSULE, is $0.2567 per EA — about 15% below DILTIAZEM 24H ER(CD) 300 MG CP.

Who manufactures DILTIAZEM 24H ER(CD) 300 MG CP?

DILTIAZEM 24H ER(CD) 300 MG CP (NDC 50742025190) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.